Partners

Developing a curative gene therapy for Crigler-Najjar syndrome.
The CureCN project has ended.

CureCN is highly multidisciplinary consortium with 11 partners from six European countries. They have been chosen for their complementary scientific excellence, technical expertise, and experience in translational research to reach the goals of the CureCN project.

CureCN Partners at a glance

External collaborators

International Centre for Genetic Engineering and Biotechnology (ICGEB)